Protection of hemopoietic cells during chemotherapy or radiotherapy
US5595973A · kind A · utility
22Cited by
1References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 12, 1994 |
| Grant date | Jan 21, 1997 |
| Priority date | — |
| Expiry date | Sep 12, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of promoting regeneration of hemopoietic cells in a subject undergoing chemotherapy or radiotherapy, which method includes the steps of (i) administering to the subject a first amount of a hemopoiesis inhibitory factor, the first amount being effective to reduce the proliferation of hemopoietic cells during the chemotherapy or radiotherapy; and (ii) after the chemotherapy or radiotherapy, administering to the subject a second amount of a hemopoiesis growth factor, the second amount being effective to stimulate the proliferation of hemopoietic cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.